BG61972B1 - Бициклични кондензирани пиридини - Google Patents

Бициклични кондензирани пиридини Download PDF

Info

Publication number
BG61972B1
BG61972B1 BG101746A BG10174697A BG61972B1 BG 61972 B1 BG61972 B1 BG 61972B1 BG 101746 A BG101746 A BG 101746A BG 10174697 A BG10174697 A BG 10174697A BG 61972 B1 BG61972 B1 BG 61972B1
Authority
BG
Bulgaria
Prior art keywords
carbon atoms
straight
branched
substituted
formula
Prior art date
Application number
BG101746A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101746A (en
Inventor
Arndt Brandes
Michael Logers
Gunter Schmidt
Rolf Angerbauer
Carsten Schmeck
Klaus-Dieter Bremm
Hilmar Bischoff
Delf Schmidt
Joachim Schuhmacher
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BG101746A publication Critical patent/BG101746A/xx
Publication of BG61972B1 publication Critical patent/BG61972B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG101746A 1996-07-08 1997-07-04 Бициклични кондензирани пиридини BG61972B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19627430A DE19627430A1 (de) 1996-07-08 1996-07-08 Bicyclisch kondensierte Pyridine

Publications (2)

Publication Number Publication Date
BG101746A BG101746A (en) 1998-03-31
BG61972B1 true BG61972B1 (bg) 1998-11-30

Family

ID=7799218

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101746A BG61972B1 (bg) 1996-07-08 1997-07-04 Бициклични кондензирани пиридини

Country Status (30)

Country Link
US (1) US6063788A (fr)
EP (1) EP0825185A1 (fr)
JP (1) JPH1067751A (fr)
KR (1) KR980009247A (fr)
CN (1) CN1172803A (fr)
AR (1) AR007716A1 (fr)
AU (1) AU722365B2 (fr)
BG (1) BG61972B1 (fr)
BR (1) BR9703886A (fr)
CA (1) CA2209609A1 (fr)
CO (1) CO4870759A1 (fr)
CZ (1) CZ214797A3 (fr)
DE (1) DE19627430A1 (fr)
EE (1) EE9700151A (fr)
HN (1) HN1997000082A (fr)
HR (1) HRP970331A2 (fr)
HU (1) HUP9701158A1 (fr)
ID (1) ID17659A (fr)
IL (1) IL121235A0 (fr)
MA (1) MA24261A1 (fr)
NO (1) NO308738B1 (fr)
NZ (1) NZ328260A (fr)
PE (1) PE87798A1 (fr)
PL (1) PL320954A1 (fr)
SG (1) SG46782A1 (fr)
SK (1) SK92697A3 (fr)
TN (1) TNSN97116A1 (fr)
TR (1) TR199700583A2 (fr)
YU (1) YU28897A (fr)
ZA (1) ZA976021B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
DE69907960T2 (de) 1998-12-23 2004-02-26 G.D. Searle Llc, Chicago Kombinationen von ileumgallensäuretransports inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen
JP2002533414A (ja) 1998-12-23 2002-10-08 ジー.ディー.サール エルエルシー 心臓血管に適用するための回腸胆汁酸輸送阻害剤および胆汁酸隔離剤の組み合わせ
ES2200587T3 (es) 1998-12-23 2004-03-01 G.D. Searle Llc Combinaciones de inhibidors del transporte de acidos biliares del ileon e inhibidores de la proteina de transferencia de colesteril ester para indicaciones cardiovasculares.
EA009466B1 (ru) 1998-12-23 2007-12-28 Джи.Ди. Сирл Ллс Ингибитор белка, переносящего эфир холестерила
WO2000038721A1 (fr) 1998-12-23 2000-07-06 G.D. Searle Llc Combinaisons d'inhibiteurs de la proteine de transfert du cholesteryle-ester et de derives de l'acide nicotinique utilisees dans le cadre de troubles cardio-vasculaires
US6569905B1 (en) 1998-12-23 2003-05-27 G.D. Searle, Llc Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US6924313B1 (en) 1999-09-23 2005-08-02 Pfizer Inc. Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US6683113B2 (en) * 1999-09-23 2004-01-27 Pharmacia Corporation (R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
EP1286984A2 (fr) 2000-03-10 2003-03-05 Pharmacia Corporation Procede de preparation de tetrahydrobenzothiepines
US20040219619A1 (en) * 2000-07-21 2004-11-04 Ester Fernandez-Salas Methods of identifying compounds that alter toxin persistence and/or protease activity
US20050239782A1 (en) * 2001-04-18 2005-10-27 Heintzelman Geoffrey R Arylindenopyridines and related therapeutic and prophylactic methods
US6958328B2 (en) 2001-04-18 2005-10-25 Ortho-Mcneil Pharmaceutical, Inc Arylindenopyridines and related therapeutic and prophylactic methods
US6903109B2 (en) 2001-04-18 2005-06-07 Ortho-Muniel Pharmaceutical, Inc. Arylindenopyridines and related therapeutic and prophylactic methods
EA006777B1 (ru) 2001-06-22 2006-04-28 Пфайзер Продактс Инк. Фармацевтические композиции адсорбатов аморфного лекарственного средства
BR0210518A (pt) 2001-06-22 2004-06-22 Pfizer Prod Inc Composições farmacêuticas de dispersões de drogas e polìmeros neutros
US6740663B2 (en) 2001-11-02 2004-05-25 G.D. Searle, Llc Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
US6852753B2 (en) 2002-01-17 2005-02-08 Pharmacia Corporation Alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
EP1469832B2 (fr) * 2002-02-01 2016-10-26 Bend Research, Inc. Compositions pharmaceutiques de dispersions amorphes de medicaments et materiaux formant des microphases lipophiles
US20040127510A1 (en) * 2002-04-16 2004-07-01 Heintzelman Geoffrey R. Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
CA2532931A1 (fr) * 2003-08-04 2005-02-10 Pfizer Products Inc. Compositions pharmaceutiques a base d'adsorbats de medicaments amorphes et de produits aptes a former des microphases lipophiles
EP1670446A2 (fr) 2003-09-26 2006-06-21 Japan Tobacco Inc. Procede pour inhiber la production de lipoproteines restantes
MXPA06003927A (es) 2003-10-08 2008-02-07 Lilly Co Eli Compuestos y metodos para tratar dislipidemia.
US20070208003A1 (en) 2004-03-26 2007-09-06 Bell Michael G Compounds and methods for treating dyslipidemia
SI1828137T1 (sl) * 2004-12-18 2012-08-31 Bayer Pharma AG 4-cikloalkil-substituirani derivati tetrahidrokinolina in njihova uporaba kot zdravila
EP1844078B1 (fr) 2005-02-03 2016-09-28 Bend Research, Inc Compositions pharmaceutiques a efficacite amelioree
WO2007048027A2 (fr) 2005-10-21 2007-04-26 Novartis Ag Combinaison de composes organiques
DE102006012548A1 (de) * 2006-03-18 2007-09-20 Bayer Healthcare Ag Substituierte Chromanol-Derivate und ihre Verwendung
PA8801401A1 (es) * 2007-10-25 2009-05-15 Janssen Pharmaceutica Nv Arilindenopirimidinas y su uso como adenosina a2a
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) * 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
NO177005C (no) * 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
ZA911046B (en) * 1990-02-26 1992-10-28 Squibb & Sons Inc Quinoline and pyridine anchors for hmg-coa reductase inhibitors
JPH059179A (ja) * 1990-09-27 1993-01-19 Takeda Chem Ind Ltd 複素環化合物、その製造法及びacat阻害剤

Also Published As

Publication number Publication date
PL320954A1 (en) 1998-01-19
ID17659A (id) 1998-01-15
CN1172803A (zh) 1998-02-11
IL121235A0 (en) 1998-01-04
SG46782A1 (en) 1998-02-20
YU28897A (sh) 2000-03-21
NO308738B1 (no) 2000-10-23
HUP9701158A1 (hu) 1999-09-28
BR9703886A (pt) 1998-11-03
NZ328260A (en) 1998-09-24
AR007716A1 (es) 1999-11-10
DE19627430A1 (de) 1998-01-15
HRP970331A2 (en) 1998-08-31
HU9701158D0 (en) 1997-09-29
SK92697A3 (en) 1998-02-04
PE87798A1 (es) 1999-02-13
EE9700151A (et) 1998-02-16
AU722365B2 (en) 2000-08-03
CA2209609A1 (fr) 1998-01-08
MA24261A1 (fr) 1998-04-01
TNSN97116A1 (fr) 2005-03-15
BG101746A (en) 1998-03-31
JPH1067751A (ja) 1998-03-10
ZA976021B (en) 1998-02-02
NO973144D0 (no) 1997-07-07
CO4870759A1 (es) 1999-12-27
CZ214797A3 (cs) 1998-01-14
AU2844897A (en) 1998-01-15
KR980009247A (ko) 1998-04-30
HN1997000082A (es) 1997-12-26
NO973144L (no) 1998-01-09
US6063788A (en) 2000-05-16
EP0825185A1 (fr) 1998-02-25
TR199700583A2 (xx) 1998-01-21

Similar Documents

Publication Publication Date Title
BG61972B1 (bg) Бициклични кондензирани пиридини
CA2209825C (fr) Pyridines avec condensation heterocyclique
KR100473299B1 (ko) 시클로알카노-피리딘
US6291477B1 (en) Tetrahydroquinolines, processes for their preparation, pharmaceutical compositions containing them, and their use to prevent or treat hyperlipoproteinaemia
US7192971B2 (en) 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
US4260764A (en) 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
US6207671B1 (en) Cycloalkano-pyridines
JP2001513790A (ja) 5−オキシ置換キノリン類およびコレステロールエステル輸送タンパク質阻害剤としてのそれらの使用
JP3538431B2 (ja) 腫瘍細胞増殖予防薬を調製するためのアミンの使用
US6121330A (en) 5-Hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia
AU730109B2 (en) 2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemia
JP2001517646A (ja) ベンジルビフェニルおよび類似化合物、ならびに動脈硬化症および異脂肪血症を治療するためのそれらの適用
US4405626A (en) 9-Hydroxyoctahydrobenzo(c)quinolines analgesic compositions containing them and processes for producing analgesic with them
MXPA97005093A (en) Bicicli condensed pyridine
MXPA97005084A (en) Condensed pyridine with heterocicles, procedure for its production and its use immediately
IL139706A (en) 3-amino-3-cyclopentyl-1-(4-trifluoromethyl phenyl)-propenone and its derivatives